OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids as therapeutics for PTSD
Brenda Sbarski, Irit Akirav
Pharmacology & Therapeutics (2020) Vol. 211, pp. 107551-107551
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Terahertz Photons Improve Cognitive Functions in Posttraumatic Stress Disorder
Yun Yu, Kaijie Wu, Yang Xiao, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 51

CB1 Cannabinoid Receptor Signaling and Biased Signaling
Luciana M. Leo, Mary E. Abood
Molecules (2021) Vol. 26, Iss. 17, pp. 5413-5413
Open Access | Times Cited: 74

Endocannabinoids, cannabinoids and the regulation of anxiety
Gavin N. Petrie, Andrei S. Nastase, Robert J. Aukema, et al.
Neuropharmacology (2021) Vol. 195, pp. 108626-108626
Closed Access | Times Cited: 57

Meet Your Stress Management Professionals: The Endocannabinoids
Terri A. deRoon‐Cassini, Todd M. Stollenwerk, Margaret Beatka, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 10, pp. 953-968
Open Access | Times Cited: 48

Low brain endocannabinoids associated with persistent non-goal directed nighttime hyperactivity after traumatic brain injury in mice
Alexandra Vogel, Annett Wilken‐Schmitz, Regina Hummel, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 40

Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence
Uri Bright, Irit Akirav
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5526-5526
Open Access | Times Cited: 27

Review of otential sychedelic reatments for PTSD
Ryan L. Henner, Matcheri S. Keshavan, Kevin P. Hill
Journal of the Neurological Sciences (2022) Vol. 439, pp. 120302-120302
Closed Access | Times Cited: 25

Effect of Dexmedetomidine on Posttraumatic Stress Disorder in Patients Undergoing Emergency Trauma Surgery
Youjia Yu, Yan Li, Dan Han, et al.
JAMA Network Open (2023) Vol. 6, Iss. 6, pp. e2318611-e2318611
Open Access | Times Cited: 12

Cannabidiol Modulates Alterations in PFC microRNAs in a Rat Model of Depression
Uri Bright, Irit Akirav
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2052-2052
Open Access | Times Cited: 11

The endocannabinoid system in the amygdala and modulation of fear
Ozge Gunduz‐Cinar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 105, pp. 110116-110116
Open Access | Times Cited: 29

Brain region specific regulation of anandamide (down) and sphingosine-1-phosphate (up) in association with anxiety (AEA) and resilience (S1P) in a mouse model of chronic unpredictable mild stress
Caroline Fischer, Dominique Thomas, Robert Gurke, et al.
Pflügers Archiv - European Journal of Physiology (2024) Vol. 476, Iss. 12, pp. 1863-1880
Open Access | Times Cited: 3

Long‐term molecular differences between resilient and susceptible mice after a single traumatic exposure
Diego Pascual Cuadrado, Hristo Todorov, Raissa Lerner, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 17, pp. 4161-4180
Open Access | Times Cited: 18

Enhancing Endocannabinoid Signaling via β-Catenin in the Nucleus Accumbens Attenuates PTSD- and Depression-like Behavior of Male Rats
Tomer Mizrachi Zer‐Aviv, Larglinda Islami, Peter J. Hamilton, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1789-1789
Open Access | Times Cited: 13

Regular cannabis use is associated with history of childhood and lifetime trauma in a non-clinical community sample
Anahita Bassir Nia, Jeremy Weleff, Nia Fogelman, et al.
Journal of Psychiatric Research (2023) Vol. 159, pp. 159-164
Open Access | Times Cited: 7

From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?
Rafael Mariano de Bitencourt, Reinaldo Ν. Takahashi, E.A. Carlini
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 16

Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review
Luca Steardo, Elvira Anna Carbone, Giulia Menculini, et al.
Life (2021) Vol. 11, Iss. 3, pp. 214-214
Open Access | Times Cited: 14

Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches
Veronika Kondev, Nathan D. Winters, Sachin Patel
International review of neurobiology (2021), pp. 143-193
Closed Access | Times Cited: 12

MicroRNAs as biomarker and novel therapeutic target for posttraumatic stress disorder in Veterans
Sudhiranjan Gupta, Rakeshwar S. Guleria, Yvette Z. Szabo
Psychiatry Research (2021) Vol. 305, pp. 114252-114252
Open Access | Times Cited: 11

New recognition of the heart–brain axis and its implication in the pathogenesis and treatment of PTSD
Haipeng Li, Hongliang Cheng, Keke Ding, et al.
European Journal of Neuroscience (2024) Vol. 60, Iss. 4, pp. 4661-4683
Open Access | Times Cited: 1

Biomedical Implications of Plant-based Principles as Antidepressants: Prospects for Novel Drug Development
Khushboo, Abhishek Kumar, Bechan Sharma
Mini-Reviews in Medicinal Chemistry (2021) Vol. 22, Iss. 6, pp. 904-926
Closed Access | Times Cited: 9

The Impact of Electroacupuncture Early Intervention on the Brain Lipidome in a Mouse Model of Post-traumatic Stress Disorder
Cuihong Zhou, Fen Xue, Qingqing Shi, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 6

Application of Drug Efficiency Index Metric for Analysis of Post-Traumatic Stress Disorder and Treatment Resistant Depression Gene Expression Profiles
Nicolas Borisov, Yaroslav Ilnytskyy, Boseon Byeon, et al.
Psychoactives (2023) Vol. 2, Iss. 2, pp. 92-112
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top